Article
DNA-based test: when and why to apply it to primary hyperparathyroidism clinical phenotypes.
Journal of internal medicine - 1 Jul 2009
Falchetti A, Marini F, Giusti F, Cavalli L, Cavalli T, Brandi M L
Abstract excerpt
Several cancer-related genes have been discovered and molecular test for the cancer genetic risk assessment has been widely increasing. Disorders such as Multiple Endocrine Neoplasia syndromes have received benefits from the identification of the responsible genes whose mutations account for the genetic susceptibility to develop endocrine tumours. Primary hyperparathyroidism (PHPT)is a clinical phenotype...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
